Meta-analysis shows perioperative denosumab increases local recurrence in giant cell tumor patients.
A Common Bone Tumor Drug May Raise the Risk of Cancer Coming Back
This meta-analysis evaluated perioperative denosumab in 1,551 patients undergoing surgical management of giant cell tumor. The authors synth…
Taking a common bone tumor drug before and after surgery nearly tripled the chance of the tumor growing back in a new analysis of 1,551 pati…
Arthroscopy-assisted curettage and bone grafting for proximal femur giant cell tumor in a 25-year-old man
Single case report suggests possible approach for treating a rare bone tumor in the hip
A case report describes a 25-year-old man with a giant cell tumor of the proximal femur who underwent arthroscopy-assisted curettage and bon…
Doctors used a small camera to remove a rare hip tumor in one patient, successfully controlling the growth while keeping the joint working n…